Dupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT Registry

Simple item page
dc.contributor.authorLaserna Mendieta, Emilio J.
dc.contributor.authorÚbeda Vargas. Victoria
dc.contributor.authorAmorena, Edurne
dc.contributor.authorSavarino, Edoardo V.
dc.contributor.authorCasabona Francés, Sergio
dc.contributor.authorColetta, Marina
dc.contributor.authorMolina Infante, Javier
dc.contributor.authorPérez Martínez, Isabel
dc.contributor.authorRossi, Carlo María
dc.contributor.authorHonrubia López, Raúl
dc.date.accessioned2026-07-10T08:54:12Z
dc.date.available2026-07-10T08:54:12Z
dc.date.issued2026
dc.description.abstractReal-world data on dupilumab for eosinophilic esophagitis (EoE), particularly regarding flexible dosing and fibrostenotic phenotypes, are scarce. Objective: To evaluate the effectiveness and safety of dupilumab in clinical practice using the EoE CONNECT registry.en
dc.description.filiationUEM
dc.description.impact8.5 JCR Q1 2025
dc.description.impact2.422 SJR Q1 2025
dc.description.impactNo data IDR 2024
dc.description.sponsorshipAstraZeneca
dc.description.sponsorshipEsoCap Biotech
dc.description.sponsorshipSanofi Regeneron Pharmaceuticals Inc.
dc.description.sponsorshipVer más financiación en 10.14309/ajg.0000000000004088
dc.identifier.citationLaserna-Mendieta, E. J., Úbeda-Vargas, V., Amorena, E., Savarino, E. V., Casabona-Francés, S., Coletta, M., Molina-Infante, J., Pérez-Martínez, I., Rossi, C. M., Dilaghi, E., Guagnozzi, D., Blas-Jhon, L., Betoré, E., Fernández-Fernández, S., Naves, J. E., Roales, V., Piccirelli, S., Granja-Navacerrada, A., Honrubia-López, R., … Lucendo, A. J. (2026). Dupilumab for eosinophilic esophagitis in adolescents and adults: Real-world outcomes across different dosing regimens from the eoe connect registry. American Journal of Gastroenterology. https://doi.org/10.14309/ajg.0000000000004088
dc.identifier.doi10.14309/ajg.0000000000004088
dc.identifier.issn0002-9270
dc.identifier.issn1572-0241
dc.identifier.urihttps://hdl.handle.net/11268/17262
dc.language.isoeng
dc.peerreviewedSi
dc.relation.publisherversionhttp://doi.org/10.14309/ajg.0000000000004088
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.otherMedicina
dc.subject.otherEsofagitis Eosinofílica
dc.subject.otherEfectos Colaterales y Reacciones Adversas Relacionados con Medicamentos
dc.subject.otherPráctica Clínica Basada en la Evidencia
dc.subject.sdgGoal 3: Ensure healthy lives and promote well-being for all at all ages
dc.subject.unescoTratamiento médico
dc.subject.unescoSistema digestivo
dc.subject.unescoEfectos químicos
dc.titleDupilumab for Eosinophilic Esophagitis in Adolescents and Adults: Real-World Outcomes Across Different Dosing Regimens from the EoE CONNECT Registryen
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Dupilumab for Eosinophilic.pdf
Size:
891.72 KB
Format:
Adobe Portable Document Format
Download

Collections

Área de Ciencias de la Salud